Ariad S, Clifford D, Penfold G, MacPhail A P, Bezwoda W R
Department of Medicine, University of the Witwatersrand Medical School, Parktown, Johannesburg, South Africa.
Eur J Haematol. 1992 Aug;49(2):59-62. doi: 10.1111/j.1600-0609.1992.tb00031.x.
Immunoreactive erythropoietin levels were measured in 42 patients with lymphoid malignancies with anaemia and bone marrow involvement. Results were compared to a control group of 16 patients suffering from anaemia due to other causes. Significant inverse correlations between serum erythropoietin level and haemoglobin concentration were shown for the patients with lymphoid malignancies and also for the control subjects. Overall, the erythropoietin levels of patients with lymphoid malignancies with bone marrow infiltration and with normal renal function did not differ significantly from erythropoietin levels of the anaemic controls. We conclude that anaemia in patients with lymphoproliferative disorders with bone marrow infiltration and normal renal function is caused primarily by a diminished/inadequate response to erythropoietin at the level of the target cell.
对42例伴有贫血和骨髓受累的淋巴系统恶性肿瘤患者测定了免疫反应性促红细胞生成素水平。将结果与16例因其他原因贫血的患者组成的对照组进行比较。淋巴系统恶性肿瘤患者和对照组血清促红细胞生成素水平与血红蛋白浓度之间均显示出显著的负相关。总体而言,骨髓浸润且肾功能正常的淋巴系统恶性肿瘤患者的促红细胞生成素水平与贫血对照组的促红细胞生成素水平无显著差异。我们得出结论,骨髓浸润且肾功能正常的淋巴增殖性疾病患者的贫血主要是由于靶细胞水平对促红细胞生成素的反应减弱/不足所致。